Added to YB: 2024-12-18
Pitch date: 2024-12-18
ENZ [neutral]
Enzo Biochem, Inc.
-0.16%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$35.7M
Pitch Price
$0.70
Price Target
N/A
Dividend
14.68%
EV/EBITDA
-0.21
P/E
-4.53
EV/Sales
0.07
Sector
Life Sciences Tools and Services
Category
dividend
Sell-Off Continues for Enzo Biochem (ENZ) as Lack of Clear Strategy Worsens
ENZ (pass): Tough Q at ELS, puzzling 10% dividend given cash burn. No clear strategy despite subscale business & quasi-liquidation. Couchman hire suggests reverse merger for NOL monetization. Sell-off punitive but understandable. Reverse merger logical: spread G&A costs, use tax losses. 70c/share seems overdone.
Read full article (1 min)